Evidence map›Paper›PMID 42761655›Full record

ArticleJournal of participatory research methods2026

Implementation Strategies for Strengthening Community and Stakeholder Engagement in Clinical and Translational Pilot Studies.

Sarah K Brewer, Siyu Chen, Thomas W Concannon, Robert D Sege, Alice Rushforth, Aviva Must, Nadia Prokofieva, Lisa C Welch

Abstract read
In one paragraph

Article in Journal of participatory research methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah K BrewerTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Siyu ChenTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Thomas W ConcannonTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Robert D SegeTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Alice RushforthTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Aviva MustTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Nadia ProkofievaTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.
Lisa C WelchTufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA.

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
Tufts Clinical and Translational Science Institute (Clinical Trial Design Labs Supplement)UM1TR004398 · NCATS · TUFTS UNIVERSITY BOSTON · PI Harry P. Selker · 2023 to 2026
$44.5M
NCATS NIH HHS UL1 TR002544NCATS NIH HHS UM1 TR004398
6 · The paper itself

Abstract

This article details participatory strategies in modestly funded, short-term studies that shape larger clinical and translational research. Specifically, we document engagement practices and strategies used in small-scale pilot studies for which the funder required applicants have a community and stakeholder engagement (CSE) plan. Drawing on the broadly-engaged team science framework, we identify practices that facilitate engagement in these studies, challenges, and potential strategies for addressing identified challenges. Investigators can implement many of the identified practices and strategies, whereas others require system-level changes by funders and/or research support organizations. At the project level, investigator practices that facilitate initial engagement include seeking alignment between stakeholder priorities and study goals and using existing personal and professional networks. Sustained and valuable CSE is enabled by drawing on relevant stakeholder expertise, clear PI communication, and building collaborative teams. Challenges and potential solutions include conducting effective team meetings, particularly with larger groups, which could be optimized by building and sustaining authentic stakeholder relationships prior to online interactions. Additionally, seeking to understand and be responsive to stakeholders' perspectives on what makes engagement meaningful - at the beginning and throughout the study - is essential to build trust and facilitate productive and authentic engagement. Funders and research support organizations play important roles in shaping a research context conducive to authentic stakeholder participation. For example, investigators experience challenges with engagement throughout a study lifecycle, and research support organizations can provide accessible CSE expertise. Establishing new stakeholder contacts is a barrier for many investigators, and funders and research support organizations can address this by training investigators, facilitating connections, and preparing stakeholders for engagement. Insufficient CSE funding, limited stakeholder capacity, and barriers to non-scientist engagement due to standard research practices present additional obstacles that require funders to promote the cultural change required to foster engagement. These participatory strategies and recommendations can facilitate the implementation of CSE into the full translational process by beginning with preliminary studies.

Indexed as

Clinical and Translational ScienceClinical and Translational Science Award (CTSA)Community EngagementPilot StudiesStakeholder Engagement

Identifiers

PMID42761655
PMCPMC13588279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.